GSP Crop Science Releases Q3FY26 Investor Presentation Ahead of April 17 Earnings Call
GSP Crop Science Limited has released its investor presentation ahead of the April 17, 2026 earnings conference call, revealing robust financial performance for Q3 and 9M FY26. The company reported consolidated revenue growth of 14% to ₹11,146 million and EBITDA growth of 32% to ₹1,538 million for the nine-month period, primarily driven by strong domestic B2C segment performance and international business expansion.
*this image is generated using AI for illustrative purposes only.
GSP Crop Science Limited has released its investor presentation for the upcoming earnings conference call scheduled for April 17, 2026. The company informed stock exchanges BSE and NSE about the presentation availability through a regulatory filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Conference Call Details
The earnings call remains scheduled for Friday, April 17, 2026, where management will discuss the company's financial performance for the third quarter and nine months ended December 31, 2025.
| Parameter: | Details |
|---|---|
| Date: | Friday, April 17, 2026 |
| Time: | 3:30 PM IST |
| Host: | Equirus Securities |
| Focus: | Q3 & 9M FY26 performance |
| Format: | Management discussion followed by Q&A |
Financial Performance Highlights
The investor presentation reveals strong consolidated financial performance for the nine-month period, with significant growth across key metrics.
Consolidated Results (9M FY26)
| Metric: | 9M FY25 (₹ Million) | 9M FY26 (₹ Million) | Growth (%) |
|---|---|---|---|
| Revenue: | 9,794 | 11,146 | +14% |
| EBITDA: | 1,168 | 1,538 | +32% |
| PAT: | 596 | 751 | +26% |
| EBITDA Margin: | 11.92% | 13.80% | +188 bps |
| PAT Margin: | 6.09% | 6.74% | +65 bps |
Standalone Performance (9M FY26)
| Metric: | 9M FY25 (₹ Million) | 9M FY26 (₹ Million) | Growth (%) |
|---|---|---|---|
| Revenue: | 10,799 | 11,766 | +9% |
| EBITDA: | 1,058 | 1,296 | +23% |
| PAT: | 533 | 682 | +28% |
| EBITDA Margin: | 9.79% | 11.01% | +122 bps |
| PAT Margin: | 4.93% | 5.80% | +87 bps |
Business Performance Drivers
The revenue growth was primarily driven by increased business in the domestic B2C segment. Key product performance included new product sales of ₹366.00 million and growth in established brands including PCT-410 (₹80.00 million increase), Torch (₹107.00 million increase), Author (₹90.00 million increase), and Runout (₹47.00 million increase).
The company's international business showed strong momentum with 20% growth over the previous year, driven by planned sales in Brazil, USA, and Africa regions. New registrations in Brazil for Chlorpyrifos contributed to improved sales performance.
Management Participation
The conference call will feature key members of GSP Crop Science's senior management team, with Chairman & Managing Director Mr. Bhavesh Vrajmohan Shah and Executive Director (Finance) & CFO Mr. Shail Jayesh Shah leading the discussion.
Access Information
Equirus Securities will host the conference call with multiple dial-in options for domestic and international participants. The presentation is available on the company's website at www.gspcrop.in , ensuring transparency and accessibility for all stakeholders.
Source: None/Company/INE713R01022/393c1e30-b127-4a1f-b377-c51a25daaacc.pdf
What expansion plans does GSP Crop Science have for its international operations, particularly in emerging markets beyond Brazil, USA, and Africa?
How will the company's strong margin improvement trajectory be sustained amid potential input cost pressures in the agrochemical sector?
What is GSP Crop Science's pipeline of new product launches for FY27, and how might they impact revenue growth targets?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
